Benign Migratory Glossitis: Case Report and Literature Review

Abstract

Benign migratory glossitis (BMG) is a benign, usually asymptomatic mucosal lesion of dorsal surface of the tongue, characterized by depapillated erythematous patches separated by white irregular borders. Etiology of BMG is unknown. Risk factors include psoriasis, fissured tongue, diabetes mellitus, hypersensitivity and psychological factors. We report BMG in an Egyptian soldier of UN peace keeping force, with stress as a possible etiological factor and provide literature review of this disorder. Symptomatic cases need to be treated by use of corticosteroids for relief of symptoms, along with correction of the cause.

Benign Migratory Glossitis in a-4-year-old boy: A Case Report

“…The erythematous patch occured as a result of atrophy of filiform papillae while the fungiform papillae were inflamed and mildly swollen. Regenerating filiform papillae and a mixture of keratin and neutrophil which aggregated inside the epithelium were the content of the white elevated border of the lesion [2].…”

“…However, if BMG symptom presents, appropriate symptomatic treatment can be given [4]. Symptomatic lesions can be treated through topical medication from group corticosteroid, anasthetic, anti-inflammation, antihistamine and anxiolytic [2]. Nutrition education and diet modification are recommended.…”

“…It is often detected on routine examination of the oral mucosa [1]. In some literatures, other terms often used are geographic tongue, erythema migrans, glossitis exfoliative, wandering rash and many more [2]. This condition was first reported by Rayer in 1831 [3].…”

“…1), they are oblate or circular, spiral and wavy [4]. Benign Migratory Glossitis can be asymptomatic or symptomatic like pain, burning sensation, discomfort, sensitivity to spicy, hot and sour food [2].…”

“…No specific curative treatment exists for benign migratory glossitis. Although treatment is not necessary, usually symptomatic relief may be provided through anti-inflammatory mouthwashes, topical anesthetics agents, or topical corticosteroids [2]. In BMG management, an important aspect that must be noticed is the patients or their companion's information regarding the complained condition.…”